Skip to content
S8981Senate2021-2022 Session

No HIV Meds Pre-Approval

Official title

“Prohibits health insurers from requiring prior authorization for anti-retroviral medication used to treat and prevent HIV infection”

Sponsor Pete HarckhamSD-40Affects Health
Status
In Senate Committee
Health
Impact
6/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill prohibits health insurers in New York from requiring prior authorization for anti-retroviral HIV medication, while allowing denial if not medically necessary.

Why it matters

  1. Speeds up access to HIV treatment and prevention. By eliminating prior authorization requirements, patients can receive anti-retroviral medications more quickly, which is crucial for both timely HIV treatment and effective prevention (such as PrEP).

  2. Reduces administrative barriers for healthcare providers. Doctors and clinics will spend less time on paperwork and insurance approvals, allowing them to focus more on patient care and potentially improving adherence rates.

  3. Addresses health equity concerns. Streamlining access to anti-retroviral drugs can help reduce disparities in HIV outcomes, especially for marginalized communities that may face greater hurdles navigating insurance requirements.

  4. Maintains insurer oversight for medical necessity. The bill balances faster access with cost controls by still permitting insurers to deny coverage if the medication is later found not to be medically necessary, preventing potential misuse.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

No HIV Meds Pre-Approval

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Pete Harckham

Senator · Senate District 40

Chair, Alcoholism And Substance Abuse

No co-sponsors yet.

History

  1. Referred to health

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

8981

IN SENATE

May 3, 2022

Introduced by Sen. HARCKHAM -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT to amend the public health law and the insurance law, in relation to prohibiting health insurers from requiring prior authorization for anti-retroviral medication used to treat and prevent HIV infection

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Section 4406-c of the public health law is amended by adding a new subdivision 13 to read as follows:

13. A health care plan which provides prescription drug coverage shall not require a prior authorization determination for anti-retroviral medication used to treat and prevent HIV infection. Nothing in this subdivision shall prohibit a health care plan from denying a claim for such services if the services are subsequently determined not medically necessary.

§ 2. Section 3217-b of the insurance law is amended by adding a new subsection (o) to read as follows:

(o) An insurer which provides prescription drug coverage shall not require a prior authorization determination for anti-retroviral medication used to treat and prevent HIV infection. Nothing in this subsection shall prohibit an insurer from denying a claim for such services if the services are subsequently determined not medically necessary.

§ 3. Section 4325 of the insurance law is amended by adding a new subsection (p) to read as follows:

(p) A corporation organized under this article which provides prescription drug coverage shall not require a prior authorization determination for anti-retroviral medication used to treat and prevent HIV infection. Nothing in this subsection shall prohibit a corporation organized under this article from denying a claim for such services if the services are subsequently determined not medically necessary.

§ 4. This act shall take effect on the one hundred eightieth day after it shall have become a law.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD14812-02-2

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law and the insurance law, in relation to prohibiting health insurers from requiring prior authorization for anti-retroviral medication used to treat and prevent HIV infection

PURPOSE::

Prohibits health insurers from requiring prior authorization for antire- troviral medication used to treat and prevent HIV infection

Summary of provisions

Section 1 amends section 4406-c of the public health law by requiring health care plans which provide prescription drug coverage shall not require a prior authorization determination for anti-retroviral medica- tion used to treat and prevent HIV infection. Nothing in this subdivi- sion shall prohibit a health care plan from denying a claim for such services if the services are subsequently determined not medically necessary.

Section 2 amends section 3217-b of the insurance law which provides that an insurer that provides prescription drug coverage shall not require a prior authorization determination for anti-retroviral medication used to treat and prevent HIV infection. Nothing in this subdivision shall prohibit a health care plan from denying a claim for such services if the services are subsequently determined not medically necessary.

Section 3 amends section 4325 of the insurance law by providing that a corporation organized under this article that provides prescription drug coverage shall not require a prior authorization determination for antiretroviral medication used to treat and prevent HIV infection. Noth- ing in this subdivision shall prohibit a health care plan from denying a claim for such services if the services are subsequently determined not medically necessary.

Section 4 provides the effective date

JUSTIFICATION::

Anti-retroviral medications are currently used to maintain symptoms associated with human immunodeficiency virus (HIV). Persons diagnosed with HIV are advised to start antiretroviral therapy as soon as possible to minimize damage to their immune systems and their risk of developing AIDS. This bill seeks to remove preauthorizations for health care plans which provide prescription drug coverage for anti-retroviral medication used to treat and prevent HIV infection. Such change would allow persons diagnosed with HIV to receive their anti-retroviral medications without having to wait out the preauthorization process.

LEGISLATIVE HISTORY::

This is a new bill.

Fiscal implications

None to the State.

Effective date

This act shall take effect on the one hundred eightieth day after it shall have become a law.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.